MDL Mass Tort & Class Action Monitor
Developed to serve primarily as a litigation scouting report for plaintiff and defense counsel, insurers and legal service providers, HarrisMartin’s MDL Mass Tort & Class Action Monitor covers significant new filings and decisions in the JPML, MDL and related mass tort arenas. The quick delivery of breaking news and additional features will keep you within close range of every development occurring in the high-stakes environment of mass torts litigation — where minutes can make a difference. The MDL Mass Tort & Class Action Monitor is an online-only offering that includes frequent email updates and is available at no charge to annual and event sponsors of HarrisMartin’s CLE Conferences.
SEARCH THE ARCHIVES
Issue #32, October 2019
United Healthcare Services Inc. has sued several generic drug makers, accusing them of violating federal and state laws by conspiring to fix, increase, stabilize, or maintain prices of their drugs in order to avoid competing and keep prices high.
The New York federal judge overseeing Purdue Pharma L.P.’s Chapter 11 bankruptcy proceedings has temporarily stayed legal proceedings filed by 25 states against the OxyCotin maker and its owners, the Sackler family, ruling that continuation of the active litigation “would result in irreparable harm to the debtors and their reorganization.”
Designer Brands Inc. and DSW Shoe Warehouse Inc. have asked the U.S. Judicial Panel on Multidistrict Litigation to create an MDL docket for actions accusing them of violating the Telephone Consumer Protection Act by sending unauthorized promotional text messages.
A New Jersey judge has dismissed a proposed class action accusing Johnson & Johnson and two of its subsidiaries of raising insurance premiums by creating and perpetuating the opioid crisis, ruling that the complaint failed to adequately allege causation.
The 6th Circuit U.S. Court of Appeals has refused to dismiss or postpone a consolidated bellwether trial in the federal opioid litigation, rejecting the State of Ohio’s argument that the relief sought by the plaintiff counties duplicates the much more expansive relief that Ohio seeks in its own lawsuits pending in state court.
The 6th Circuit U.S. Court of Appeals has refused to disqualify the Ohio federal judge overseeing the opioid multidistrict litigation, rejecting the defendant drug makers’ argument that his statements concerning a personal objective to abate the opioid crisis via settlements is evidence of partiality.
A federal multidistrict litigation docket has been created for actions in which Pfizer is accusing various generic drug makers of infringing its patents for its metastatic breast cancer drug Ibrance (palbociclib).
Several school districts across the country have filed complaints against JUUL Labs Inc., accusing the company of marketing e-cigarettes to minors and causing a “youth vaping epidemic.”
A federal panel has created a multidistrict litigation docket for actions accusing certain manufacturers of conspiring to fix, raise, maintain, or stabilize the price of hard disk drive suspension assemblies sold in the United States and abroad.
Philadelphia Jury Awards $8 Billion in Punitive Damages Against Janssen at Conclusion of Risperdal Case
A Philadelphia jury has awarded plaintiffs a total of $8 billion in punitive damages at the conclusion of a Risperdal case against Janssen Pharmaceuticals Inc., sources confirmed to HarrisMartin Publishing.